Discussion

The NMI provides its customers with research and development services in the fields of life science. We offer a comprehensive range of services to the pharmaceutical, biotechnology, and biomedical technology sectors to develop, improve and launch their products.
Our portfolio includes lentiviral technology for the generation of stable cell lines for target validation. The Chromobody ® technology as a state-of-the-art tool for High Content Analysis allows to trace and visualize endogenous intracellular antigens. A rich variety of competence in the field of immunity and tumor immunology based on primary 2D and 3D cell culture and co-culture complements our service range.
We work in seeking tailored solutions for your specific needs. We manage projects from start to finish – from the planning stage, through to evaluation. Our service is trustworthy, reliable, punctual, and cost-effective. We support our customers at all stages of their preclinical process and product development.